Vivos Therapeutics (VVOS) Change in Cash (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Change in Cash of $81000.0 for Q1 2026, up 102.07% year-over-year from $40085.6 in Q1 2025, and up 107.66% quarter-over-quarter from -$1.1 million in Q4 2025.
Vivos Therapeutics (VVOS) Change in Cash (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Change in Cash for 7 consecutive years, with $81000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 102.07% year-over-year to $81000.0; the TTM figure through Mar 2026 stood at -$232000.0 (up 13.75% YoY), while the FY2025 annual figure was -$4.2 million, down 191.64% from the prior year.
- Change in Cash grew to $81000.0 in Q1 2026 per VVOS's latest filing, from -$1.1 million in the prior quarter.
- Across five years, Change in Cash topped out at $4.3 million in Q2 2024 and bottomed at -$6.2 million in Q1 2022.
- Historically, Change in Cash has averaged -$1.3 million across 5 years, with a median of -$1.1 million in 2025.
- Annual changes were most pronounced in 2024 — Change in Cash surged 238.27% — and 2025, when it sank 1974.51%.
- Vivos Therapeutics' Change in Cash stood at -$3.2 million in 2022, then jumped by 120.47% to $655000.0 in 2023, then slumped by 107.79% to -$51000.0 in 2024, then tumbled by 1974.51% to -$1.1 million in 2025, then surged by 107.66% to $81000.0 in 2026.
- Business Quant data shows VVOS's Change in Cash at $81000.0 in Q1 2026, -$1.1 million in Q4 2025, and -$1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 513.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -890.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 462.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -13.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -180.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.21 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 42.80 Mn |
| 10 | Vivos Therapeutics | 5.18 Mn | 3.38 Mn | 2.95 Mn | -336,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81,000.00 |
| Dec 31, 2025 | -1.06 Mn |
| Sep 30, 2025 | -1.32 Mn |
| Jun 30, 2025 | 2.06 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Dec 31, 2024 | -51,000.00 |
| Sep 30, 2024 | -592,000.00 |
| Jun 30, 2024 | 4.29 Mn |
| Mar 31, 2024 | 968,000.00 |
| Dec 31, 2023 | 655,000.00 |
| Sep 30, 2023 | -2.95 Mn |
| Jun 30, 2023 | -3.10 Mn |
| Mar 31, 2023 | 3.53 Mn |
| Dec 31, 2022 | -3.20 Mn |
| Sep 30, 2022 | -5.94 Mn |
| Jun 30, 2022 | -5.17 Mn |
| Mar 31, 2022 | -6.20 Mn |
| Dec 31, 2021 | -4.50 Mn |
| Sep 30, 2021 | -5.66 Mn |
| Jun 30, 2021 | 20.14 Mn |